Have any questions?
+44 1234 567 890
PROGRAM: Sepsis Update 2025 program will be available soon.
Get up to date on the current state of knowledge about the latest diagnostic and therapeutic advances of sepsis. Meet your colleagues and friends in your field and exchange ideas and experiences with them.
Improving sepsis outcomes: cutting edge in diagnostics & therapy
View program
Sepsis Update 2025 program will be available soon
Preliminary program 2025
Thursday
09:00 – 12:00: Workshops
Workshop 1: German campaign #DeutschlandErkenntSepsis (DES)
Workshop 2: European group on immunology of sepsis (EGIS)
Workshop 3: Refresher course: anti-infective management
Workshop 4: Animal models in sepsis
12:00 – 13:00 Break
13:00 – 14:50: Opening session – Transforming sepsis care: how to improve outcomes?
Chair: Michael Adamzik, Bochum, Germany; Sina Coldewey, Zurich, Switzerland
13:00 – 13:05: Opening address (Achim Kaasch, Magdeburg, Germany)
13:05 – 13:35: Key note lecture – Future directions in clinical sepsis research (Mervyn Singer, London, United Kingdom, Patron of the German Sepsis Society)
13:35 – 14:00: Modifiable mechanisms and informative archetypes in sepsis? (Evangelos J. Giamarellos-Bourboulis, Athens, Greece)
14:00 – 14:25: Translational perspectives in sepsis research (Hjalmar R. Bouma, Groningen, The Netherlands)
14:25 – 14:50: Is bigger better? – Platform trials in intensive care (Lennie Derde, Utrecht, The Netherlands)
14:50 – 15:20 Break
15:20 – 17:10: Session 1 – Unravelling sepsis mechanisms
Chair: Sandra Frank, Munich, Germany; Felix C.F. Schmitt, Heidelberg, Germany
15:20 – 15:40: The plasma lipodome in pneumonia and sepsis (Matthijs Kox, Nijmegen, The Netherlands)
15:40 – 16:00: (Epi)Genetics in sepsis: understanding susceptibility and progression (Brendon P. Scicluna, Msida, Malta)
16:00 – 16:20: The microbiome’s role in sepsis pathobiology (John Marshall, Toronto, Canada)
16:20 – 16:40: New sepsis endotypes (Lars Palmowski, Bochum, Germany)
16:40 – 17:10 Break
17:10 – 18:10 Session 2 – Focus on sepsis outcomes in clinical trials
Chair: André Scherag, Jena, Germany, Patrick Meybohm, Würzburg, Germany
17:10 – 17:30: Mortality versus days alive and free of organ support (Kathy Rowan, London, United Kingdom)
17:30 – 17:50: Shortcomings in adverse events reporting (Deborah Cook, Hamilton, Canada)
17:50 – 18:10: PICS and patient-centered outcomes (Frank Brunkhorst, Jena, Germany)
from 18:30: Get together
tba
Friday
07:30 – 08:00: Morning rounds – my worst sepsis case
Presenter: Christina Scharf-Janßen, Munich, Germany
08:00 – 09:00: Session 3 – Innovations in (early) sepsis detection
Chair: t.b.a.; Frank Bloos, Jena, Germany
08:00 – 08:20: Organ dysfunction in sepsis: how to define, how to detect? (Markus A. Weigand, Heidelberg, Germany)
08:20 – 08:40: New culture-independent detection systems for infection (Evgeny Idelevich, Greifswald, Germany)
08:40 – 09:00: Artificial intelligence for early sepsis recognition (Thorsten Brenner, Essen, Germany)
09:00 – 09:30 Break
09:30 – 10:30: Session 4 – Hemodynamics: (beyond) initial resuscitation
Chair: Mervyn Singer, London, United Kingdom; t.b.a.
09:30 – 09:50: Parameter guided initial resuscitation (Maximilian Dietrich, Heidelberg, Germany)
09:50 – 10:10: Fluid and vasopressor choices (Frank Bloos, Jena, Germany)
10:10 – 10:30: Betablockers and antiarrhythmics (Sebastian Rehberg, Bielefeld, Germany)
10:30 – 10:45 Break
10:45 – 11:45: Session 5 – Cutting edge in therapy: anti-infective management
Chair: Elham Khatamzas, Heidelberg, Germany; Jan De Waele, Ghent, Belgium
10:45 – 11:05: Empirical strategies (Mathias Pletz, Jena, Germany)
11:05 – 11:25: Prolonged / continuous administration of beta-lactams (Stefan Hagel, Jena, Germany)
11:25 – 11:45: When is it time to (de)escalate? (Jan De Waele, Ghent, Belgium)
11:45 – 12:00 Break
12:00 – 13:30: Lunchsymposia
See below
13:30 – 14:00 Break
14:00 – 15:00: Session 6 – Antibiotic therapy of S. aureus bloodstream infection
Chair: Mathias Pletz, Jena, Germany; Alexander Brinkmann, Heidenheim, Germany
14:00 – 14:20: Risk stratification in S. aureus bloodstream infection (Achim Kaasch, Magdeburg, Germany)
14:20 – 14:40: The SNAP platform trial in the EU (Marjolein Hensgens, Utrecht, The Netherlands)
14:40 – 15:00: Antibiotic combination therapy in S. aureus bloodstream infection (Siegbert Rieg, Freiburg, Germany)
15:00 – 15:30 Break
15:30 – 16:30: Session 7 – Prevention and treatment of sepsis-induced organ failure
Chair: Konstanty Szułdrzyński, Warszawa, Poland; t.b.a.
15:30 – 15:50: Targeting sepsis-induced endotheliopathy (Morten Bestle, Copenhagen, Copenhagen, Denmark)
15:50 – 16:10: Is it time to redefine ARDS? (Pro: Christoph Bösing, Mannheim, Germany; Con: Onnen Mörer, Göttingen, Germany)
16:10 – 16:30: Thiamine for renal protection (Josef Briegel, Munich, Germany)
16:30 – 17:00: Break
17:00 – 18:00: Session 8 – Up to date: the new German sepsis guidelines
Chair: Frank Brunkhorst, Jena, Germany; Christina Scharf-Janßen, Munich, Germany
17:00 – 17:20: Ventilation (Onnen Mörer, Göttingen, Germany)
17:20 – 17:40: Renal support (Stefan John, Nürnberg, Germany)
17:40 – 18:00: Additional therapies (Patrick Meybohm, Würzburg, Germany)
Saturday
07:30 – 08:00: Morning rounds – my worst sepsis case
Presenter: Jannick Clemens, Heidelberg, Germany
08:00 – 09:00: Session 9 – Nutrition and metabolism
Chair: Aileen Hill, Aachen, Germany; Jan Beneš, Prague, Czech Republic.
08:00 – 08:20: Glucose control (Gunnar Elke, Kiel, Germany)
08:20 – 08:40: Vitamins to improve organ dysfunction (tba)
08:40 – 09:00: Permissive hypofeeding (Tim Rahmel, Bochum, Germany)
09:00 – 09:30 Break
09:30 – 10:30: Session 10 – Adjuncts and recent developments 1
Chair: Thorsten Brenner, Essen, Germany; Josef Briegel, Munich, Germany
09:30 – 09:50: Update on plasma exchange (Sascha David, Zürich, Switzerland)
09:50 – 10:10: AT-II, methylen-blue … new tools for refractory septic shock? (Mervyn Singer, London, United Kingdom)
10:10 – 10:30: Mesenchymal stem cells for severe pneumonia and sepsis (Marius A. Möbius, Dresden, Germany)
10:30 – 10:45 Break
10:45 – 11:45: Session 11 – Adjuncts and recent developments 2
Chair: Nana-Maria Wagner, Würzburg, Germany; t.b.a.
10:45 – 11:05: Fludrocortisone in septic shock (Balasubramanian Venkatesh, Sydney, Australia)
11:05 – 11:25: Steroids in ARDS and CAP (Djillali Annane, Paris, France)
11:25 – 11:45: CAR-engineered immune cells: strengths and flaws (Christina Weisheit, Bonn, Germany)
11:45 – 12:00 Break
12:00 – 13:30: Lunchsymposia
See below
13:30 – 14:00 Break
14:00 – 15:00: Hot topics session
tba
Lunch Symposia
The lunch symposia take place on Friday and Saturday from 12:00-13:30 in cooperation with our partners.
Lunch Symposium Friday
Our lunch symposium on Friday is supported by Pfizer.
Schnelle Diagnostik – next generation
(Prof. Dr. med. Thorsten Brenner, Universitätsklinikum Essen, Essen)
Leitliniengerechte Antibiotikatherapie bei Sepsis
(Prof. Dr. med. Markus Weigand, Universitätsklinikum Heidelberg, Heidelberg, Chair)
Was bringt die Zukunft – ein Ausblick auf die nächsten 10 Jahre des Antibiotika-Zeitalters
(PD Dr. med. Stefan Hagel, Universitätsklinikum Jena, Jena)
Lunch Symposium Friday
Our lunch symposium on Friday is supported by Shionogi.
12:00 – 12:10: Begrüßung und Einleitung
(Prof. Dr. med. Irit Nachtigall, Vivantes Netzwerk für Gesundheit GmbH, Berlin)
12:10 – 12:30: Sepsis aus Sicht der Kardiologin
(Dr. med. Elisabeth Schönherr, Universitätsklinikum Wiener Neustadt, Wien)
12:30 – 12:50: Sepsis aus der Sicht der Infektiologin und Infektionspräventionsmedizinerin
(Prof. Dr. med. Irit Nachtigall, Vivantes Netzwerk für Gesundheit GmbH, Berlin)
12:50 – 13:10: Sepsis aus Sicht des Notfallmediziners
(Dr. med. Jan-Christoph Lewejohann, Universitätsklinikum Jena, Jena)
13:10 – 13:30: Moderierte Diskussion
(Prof. Dr. med. Irit Nachtigall)
Lunch symposium Saturday
tba
By attending the Sepsis Update, you will be eligible to earn Continuing Medical Education (CME) credits. The State Medical Association of Thuringia offers up to 23 CME credits for your active participation in this event.
Get the latest updates!
Newsletter
Subscribe to our newsletter to receive the latest news and updates about Sepsis Update!
You can unsubscribe from the mailing list at any time.
By clicking on 'Subscribe' you agree to receive the newsletter with information on Sepsis Update, as well as to its analysis through individual measurement, storage, and evaluation of opening rates and the click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can unsubscribe at any time. Please find detailed information in our privacy policy.